| J9271 | Injection, pembrolizumab, 1 mg | 28,800 | $40 | $1.2M |
| J0897 | Injection, denosumab, 1 mg | 15,920 | $20 | $286.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,110 | $110 | $229.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 440 | $150 | $66.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $130 | $55.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 870 | $60 | $54.8K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 550 | $90 | $47.2K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 2,560 | $20 | $38.4K |
| P9046 | Infusion, albumin (human), 25%, 20 ml | 2,210 | $20 | $37.5K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,460 | $10 | $32.8K |